With a Buy rating, HC Wainwright & Co. initiated coverage on ALX Oncology Holdings Inc (NASDAQ:ALXO). The price target seems to have been set at $100.00 for ALX Oncology Holdings. In the third quarter, ALX Oncology Holdings earned $0.31. The stock has a 52-week-high of $117.45 and a 52-week-low of $29.06. At the end of the last trading period, ALX Oncology Holdings closed at $82.18.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.